Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-25
DOI
10.1002/ijc.32990
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- Systemic silencing of Phd2 causes reversible immune regulatory dysfunction
- (2019) Atsushi Yamamoto et al. JOURNAL OF CLINICAL INVESTIGATION
- A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs
- (2019) Weiping Zou et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapy in Ovarian Cancer
- (2019) Weimin Wang et al. Surgical Oncology Clinics of North America
- Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
- (2019) Malgorzata Czystowska-Kuzmicz et al. Nature Communications
- Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
- (2019) Karolina Okła et al. Frontiers in Immunology
- Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11
- (2019) Xueting Lang et al. Cancer Discovery
- Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
- (2019) Peter C. Hart et al. Cell Reports
- Magnetic resonance imaging of cancer metabolism with hyperpolarized 13 C-labeled cell metabolites
- (2018) Richard L Hesketh et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
- (2018) John Wahba et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues
- (2018) Tiffany Porta Siegel et al. MOLECULAR IMAGING AND BIOLOGY
- Analysis of redox landscapes and dynamics in living cells and in vivo using genetically encoded fluorescent sensors
- (2018) Yejun Zou et al. Nature Protocols
- PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy
- (2018) Partha S. Chowdhury et al. Cancer Immunology Research
- IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
- (2018) Minkyung Song et al. NATURE
- Metabolism as a guiding force for immunity
- (2018) Jonathan Jung et al. NATURE CELL BIOLOGY
- UniProt: a worldwide hub of protein knowledge
- (2018) NUCLEIC ACIDS RESEARCH
- Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells
- (2018) Li Jiang et al. Frontiers in Immunology
- Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer
- (2017) Amirhossein Bahreyni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma
- (2017) Eva Brencicova et al. PLoS One
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Naoki Horikawa et al. CLINICAL CANCER RESEARCH
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ferroptosis: Death by Lipid Peroxidation
- (2016) Wan Seok Yang et al. TRENDS IN CELL BIOLOGY
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- The Role of Prostaglandin E 2 in Tumor-Associated Immunosuppression
- (2016) Dingzhi Wang et al. TRENDS IN MOLECULAR MEDICINE
- Synergistic COX2 Induction by IFN and TNF Self-Limits Type-1 Immunity in the Human Tumor Microenvironment
- (2016) J. L. Wong et al. Cancer Immunology Research
- Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
- (2016) Itsaso Montalbán del Barrio et al. Journal for ImmunoTherapy of Cancer
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
- (2015) Juan R. Cubillos-Ruiz et al. CELL
- Nutrient Competition: A New Axis of Tumor Immunosuppression
- (2015) Madhusudhanan Sukumar et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival
- (2015) Ulf H. Beier et al. FASEB JOURNAL
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
- (2015) Ende Zhao et al. NATURE IMMUNOLOGY
- Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
- (2015) Claudia Sorrentino et al. Oncotarget
- Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment
- (2015) Tim Schumann et al. Oncotarget
- Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
- (2014) Johannes Landskron et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
- (2014) I. B. Barsoum et al. CANCER RESEARCH
- The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
- (2014) Andrew N. Macintyre et al. Cell Metabolism
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways
- (2014) S. R. Jacobs et al. JOURNAL OF IMMUNOLOGY
- Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
- (2014) W. Cao et al. JOURNAL OF IMMUNOLOGY
- Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication
- (2014) Victoria O. Shender et al. MOLECULAR & CELLULAR PROTEOMICS
- The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
- (2014) Ana Costa et al. SEMINARS IN CANCER BIOLOGY
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma
- (2013) Riyas Vettukattil et al. HUMAN PATHOLOGY
- Lysophosphatidic Acid Inhibits CD8 T-cell Activation and Control of Tumor Progression
- (2013) S. K. Oda et al. Cancer Immunology Research
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function
- (2012) Eóin N. McNamee et al. IMMUNOLOGIC RESEARCH
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Passing the baton: the HIF switch
- (2012) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia
- (2011) Aude Carreau et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
- (2011) R. D. Michalek et al. JOURNAL OF IMMUNOLOGY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+ Effector T Cells
- (2011) Olga Efimova et al. PLoS One
- Basics and principles of radiopharmaceuticals for PET/CT
- (2010) W. Wadsak et al. EUROPEAN JOURNAL OF RADIOLOGY
- Lipid accumulation and dendritic cell dysfunction in cancer
- (2010) Donna L Herber et al. NATURE MEDICINE
- Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
- (2010) D Lane et al. ONCOGENE
- The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
- (2009) A. Greenhough et al. CARCINOGENESIS
- Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A2
- (2009) Jintang Sun et al. Cellular & Molecular Immunology
- Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
- (2008) Alexandros Daponte et al. BMC CANCER
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
- (2008) Candace M. Cham et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started